For: | He YC, Hao ZN, Li Z, Gao DW. Nanomedicine-based multimodal therapies: Recent progress and perspectives in colon cancer. World J Gastroenterol 2023; 29(4): 670-681 [PMID: 36742173 DOI: 10.3748/wjg.v29.i4.670] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v29/i4/670.htm |
Number | Citing Articles |
1 |
Qi Yu, Tongtong Wu, Wenhong Xu, Junyuan Wei, Anqi Zhao, Miaomiao Wang, Meiying Li, Guangfan Chi. PTBP1 as a potential regulator of disease. Molecular and Cellular Biochemistry 2024; 479(11): 2875 doi: 10.1007/s11010-023-04905-x
|
2 |
Jiang Fu, Li Yu, Zixu Wang, Haoyu Chen, Song Zhang, Haining Zhou. Advances in controlled release drug delivery systems based on nanomaterials in lung cancer therapy: A review. Medicine 2025; 104(6): e41415 doi: 10.1097/MD.0000000000041415
|
3 |
Wentao Yuan, Xiaolin Zhang, Hui Cong. Advances in the protein‑encoding functions of circular RNAs associated with cancer (Review). Oncology Reports 2023; 50(2) doi: 10.3892/or.2023.8597
|
4 |
Sheikh Rezzak Ali, Chinmoyee Deori, Gaurab Kr Gogoi, Naba Jyoti Borah, Prajnyan Prasad Kalita, Rubina Chowdhury, Simran Kaur, Bibhuti Bhusan Kakoti. Liposomic nano particles in the treatment of colorectal and ovarian cancer. European Journal of Medicinal Chemistry Reports 2024; 11: 100149 doi: 10.1016/j.ejmcr.2024.100149
|
5 |
Vuslat Yurut-Caloglu, Alparslan Serarslan, Gül Kanyilmaz, Esra Kaytan Saglam, Pervin Hurmuz, Didem Colpan Oksuz, Fazilet Oner Dincbas, Deniz Yalman, Zafer Kocak, Banu Atalar, Volkan Demircan, Nilufer Kilic, Murat Caloglu, Alihan Sürsal. The Impact of Malnutrition in the Radiotherapy Pathway in Geriatric Patients in the Onco-Surgical Settings on Behalf of the Turkish Society for Radiation Oncology Study Group (TROD 12-04).. European Journal of Surgical Oncology 2025; : 110057 doi: 10.1016/j.ejso.2025.110057
|
6 |
Daniel J. Lagal, Antonio M. Montes-Osuna, Alberto Ortiz-Olivencia, Candela Arribas-Parejas, Ángel Ortiz-Alcántara, Cristina Pescuezo-Castillo, José Antonio Bárcena, Carmen Alicia Padilla, Raquel Requejo-Aguilar. Tumoral Malignancy Decreases Coupled with Higher ROS and Lipid Peroxidation in HCT116 Colon Cancer Cells upon Loss of PRDX6. Antioxidants 2024; 13(7): 881 doi: 10.3390/antiox13070881
|
7 |
Puja Sandbhor, Pranoti Palkar, Sakshi Bhat, Geofrey John, Jayant S. Goda. Nanomedicine as a multimodal therapeutic paradigm against cancer: on the way forward in advancing precision therapy. Nanoscale 2024; 16(13): 6330 doi: 10.1039/D3NR06131K
|
8 |
Maria Shahzad, Huma Hameed, Ayesha Amjad, Mahtab Ahmad Khan, Inaba Shujaat Qureshi, Anam Hameed, Asad Saeed, Rabia Munir. An updated landscape on nanopharmaceutical delivery for mitigation of colon cancer. Naunyn-Schmiedeberg's Archives of Pharmacology 2025; 398(3): 2107 doi: 10.1007/s00210-024-03482-0
|